SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.30 |
Enterprise Value ($M) | -3.54 |
Book Value ($M) | -3.87 |
Book Value / Share | -1.58 |
Price / Book | -0.85 |
NCAV ($M) | -4.58 |
NCAV / Share | -1.86 |
Price / NCAV | -0.72 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -1.08 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.68 |
Current Ratio | 0.68 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8.61 |
Assets | 9.31 |
Liabilities | 13.18 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -12.55 |
Net Income | -15.75 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -11.41 |
Cash from Investing | 0.00 |
Cash from Financing | 11.27 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Fortress Biotech, Inc. | 7.90 | -96.97 | |
13G | Armistice Capital, Llc | |||
13G | Intracoastal Capital, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
12,214 | 32,023 | 38.14 | |
2,996 | 8,466 | 35.39 | |
5,453 | 20,768 | 26.26 | |
5,740 | 16,687 | 34.40 | |
(click for more detail) |
Similar Companies | |
---|---|
LQDA – Liquidia Corporation | LSTA – Lisata Therapeutics, Inc. |
LTRN – Lantern Pharma Inc. | MBRX – Moleculin Biotech, Inc. |
MEIP – MEI Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io